Background: Chondroblastomas are benign tumors that typically occur in the epiphysis of long bones. Carpal bone chondroblastomas are very rare and are known to have less aggressive behavior with no evidence of recurrence reported. Methods: We present a case of a recurrent chondroblastoma in the capitate that was treated with repeat curettage, application of phenol, and bone grafting. Results: At 3 years post surgery, the patient is disease free with excellent functional return. Conclusion: Chondroblastomas are rare within the carpus. We present a review of the literature detailing their occurrence and treatment.
Introduction
Chondroblastomas are rare benign tumors that account for less than 1% of all primary, bone tumors. 9 They typically arise in the epiphysis of the long bones and are readily treated with curettage and bone grafting. The recurrence rate of chondroblastomas has been described to be between 10% and 32%. 9 Although controversial, there are rare reports of malignant chondroblastomas in the literature. Many authors believe that in cases of a malignant chondroblastoma, further pathological review is warranted to exclude other entities such as chondroblastoma-like osteosarcoma. 6 Several reports of benign chondroblastomas with metastasis to the lungs have been described. These metastasizing lesions are microscopically indistinguishable from benign chondroblastomas, and to date there are no studies that definitively identifying the risk factors that would predict recurrence or more aggressive behavior of these tumors. 11 However, there are reports demonstrating some association between higher recurrence of these tumors and aneurysmal bone cystic changes, tumor location, or duration of symptoms. 9 Chondroblastomas have been described to occur in a wide variety of locations, most commonly in the knee and proximal humerus. Tarsal involvement has been described to occur with an incidence of 3% to 16% of all chondroblastomas. These tumors typically present in the second decade of life. 3 Chondroblastomas are extremely rare in the short bones of the hand. In the largest series of carpal neoplasms, only 6 cases of carpal chondroblastomas were reported with 3 occurring in the scaphoid (50%) and 1 in the capitate (17%). There have been 2 additional reports of chondroblastomas in the capitate, both without recurrence after curettage and bone grafting. We present a case of a recurrent capitate chondroblastoma after initial curative curettage and bone grafting. Secondary curettage and allograft bone insertion with concomitant arthrodesis of adjacent hamate secondary to cortical expansion and articular involvement of the tumor with no recurrence at 3-year follow-up was performed.
Case Report
An 18-year-old woman presented to our institution with a history of dorsal wrist pain. She had previously been diagnosed with a capitate chondroblastoma, which was treated with curettage and allograft bone insertion at an outside institution (Figures 1a and 1b ). With clear surgical margins, she was noted to have radiographic concerns of recurrent tumor within 6 months. Upon presentation to our clinic, she had a well-healed dorsal wrist scar with tenderness over the capitate and capitohamate joint. Radiographs and advanced imaging, including magnetic resonance imaging and computed tomography scans demonstrated an expansile/lytic/well-marginated lesion within the capitate that was involving the capitohamate joint (Figures 2a-2c). To address the recurrence with capitohamate articular surface expansion, she underwent excision and curettage, high-speed burr debridement, phenol application, and bone grafting with capitohamate arthrodesis ( Figures  3a and 3b ). The postoperative course was uneventful and without complications, and the pathology showed a recurrent chondroblastoma composed of uniform, well-defined cells with ovoid-to-indented nuclei and occasional nuclear grooves, scattered osteoclast-type giant cells, and foci of pericellular "chicken wire" calcifications (Figures 4a and 4b). She was placed into a short-arm cast postoperatively (Figures 5a and 5b) . At her most recent follow-up at 3 years, she was asymptomatic without any evidence of recurrence (Figures 6a and  6b ). Her range of motion and grip strength was improved and almost identical to her contralateral side.
Discussion
Chondroblastomas are rare, benign bony tumors with an incidence of 0.02% in the carpal bones. 9 Sato et al reported on a case of chondroblastoma in the capitate with secondary aneurysmal bone cyst changes and complete resolution following curettage and bone grafting. 8 The case we present describes a recurrent capitate chondroblastoma treated successfully with repeat excision using curettage, phenol application, and bone grafting with capitohamate arthrodesis secondary to expansion of the tumor to the articular surface of capitohamate joint. The arthrodesis did not result with any deficits in wrist range of motion or grip strength.
Despite reports in the literature suggesting a possible association between the presence of secondary aneurysmal bone cyst changes, tumor location, and duration of symptoms with increased risk of recurrence, there are no agreed upon histologic or clinical findings that predict an increased risk of recurrence other than an incomplete surgical excision with residual disease. 4 Histologically, our case displayed the expected findings and did not show any evidence of cellular atypia, increased mitosis, necrosis, or secondary aneurysmal bone cyst changes. To date, there has been no evidence in the literature of any association between chondroblastoma of the carpal bones and an increased risk of recurrence.
The principal treatment modality for the management of chondroblastomas is intralesional curettage and bone graft. In a series reported by Suneja et al, only 7 (13.2%) out of 52 patients had a local recurrence after treatment with only intralesional curettage. 10 Dahlin and Ivins, in 1972, reported 38 cases of chondroblastomas with 3 recurrences after curettage, which were treated with repeat curettage and bone grafting with or without radiation. 1 The presented case demonstrates a successful treatment using repeat curettage and use of chemical (phenol) cauterization with bone grafting. High-speed burring, phenol, bone cement, and cryosurgery have been recommended to reduce local recurrence of these tumors. 3 Rybak et al reported percutaneous radiofrequency ablation as an alternative method to surgery in some selected cases. 7 Despite numerous advancements and alternatives in the treatment of these lesions, at times with multiple recurrences, amputation has also been recommended. 6 Complete excision of the carpal bone has also been described as a treatment modality even in face of primary lesions; however, this can lead to significant functional sequelae. 2 In addition, considering the young age at presentation in many of these patients, the resultant possible delayed osteoarthritis of intercarpal and carpometacarpal joints could lead to persistent pain and symptoms. In the present patient, we elected to proceed with capitohamate arthrodesis after complete debridement as this has been demonstrated to cause no deficit in range of motion or grip strength with resolution of any symptoms secondary to changes at the capitohamate articulation. 5 Chondroblastomas are rare benign tumors within the carpus. Despite initial successful treatment, patients need to be followed postoperatively for the chance of recurrence, which may cause additional carpal destruction. In the case presented, the patient developed recurrence with destruction of the capitohamate joint and underwent successful reconstruction.
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